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Apoptotic Pathways: Paper Wraps Minireview
Stone Blunts Scissors
The mitochondrial pathway, shown in Figure 1A, is
triggered by proapoptotic members of the Bcl-2 family,
initially by a subset of these called the ªBH3-only sub-
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San Diego, California 92121 familyº proteins because they possess only one of the
Bcl-2 homology (BH) domains. These include Bid, Bim,
Harikari, Noxa, and a number of others. In response to
environmental cues these proteins engage another setAbout 2.2 billion years ago, as the oxygen levels on
the planet were rising, a new sort of life-form emerged, of proapoptotic Bcl-2 members, the Bax subfamily
forged from a shaky alliance of what were to become (which includes Bax, Bak, and probably Bok), loosely
the mitochondria and the remainder of the cell. The residing on the mitochondrial outer membranes or in
protomitochondria brought respiration to the partner- the cytosol. The interaction causes the latter to oligo-
ship, and with it the power to kill the new cell through merize and insert into the mitochondrial membrane
the production of reactive oxygen species, a mechanism (Eskes et al., 2000). Here the complex acts to trigger
of cell death that still exists throughout the eukaryotes. the sudden and complete release of cytochrome c and
However, it was about 1.5 billion years later, as multicel- other proteins from all of the mitochondria in the cell.
lular animals emerged, that our story probably begins. The released cytochrome c binds to Apaf-1, a cyto-
Apoptosis has now evolved as a physiological cell death solic protein. This induces Apaf-1 oligomerization, and
in response to environmental and developmental sig- the Apaf-1 ªapoptosomeº recruits and activates procas-
nals, a complex decision-making system with the mito- pase-9 (Cain et al., 2000). The active caspase-9 now
chondria at its heart. Apoptotic cell death is found recruits and activates the executioner procaspase-3.
throughout the animal kingdom, and it culminates in the Cells lacking cytochrome c are remarkably resistant to
execution, packaging, and disposal of the dying cells. stress-induced apoptosis and maintain clonogenicity
Several recent advances have contributed to an emerg- under some conditions where wild-type cells die (Li et
ing (and evolving) view of how apoptosis proceeds once al., 2000). Cells lacking Apaf-1 or caspase-9 are also
initiated, to the point that we can speculate on a pathway resistant to the induction of apoptosis via the mitochon-
for this remarkable process. This is a pathway, however, drial pathway (reviewed in Green, 1998).
that may differ in interesting ways between different types Bcl-2 and Bcl-xL (and probably other anti-apoptotic
of animals. This review will focus predominantly and ªphy- members of this family) block death by preventing the
locentricallyº on the apoptotic pathway of the chordates, mitochondrial release of the intermembrane proteins,
but will draw parallels to other phyla. including cytochrome c. Once the process gets past
Caspase Activation and Its Consequences: the mitochondria, these antiapoptotic proteins have no
Scissors Cut Paper effect (e.g., Moriishi et al., 1999; Newmeyer et al., 2000).
The key to understanding apoptosis is the activation and This does not mean, however, that there is no regulation
function of a set of proteinases, the caspases (cysteine of apoptosis beyond the mitochondria.
proteinases with specificity for aspartic acid residues). The Inhibitor of Apoptosis Proteins:
When the caspases are activated they cleave a wide Stone Blunts Scissors
variety of proteins, including certain key substrates in The functions of the Executioner's scissors, the cas-
the cell, and it is the changes in function of the latter
pases, are modulated by another set of proteins, the
that kill the cell via apoptosis. This function of some of
IAPs (inhibitor of apoptosis proteins). One of these,
the caspases is called ªexecution,º and the caspases
XIAP, binds to and inhibits the proteinase activity ofthat do this are the executioner caspases. Caspases
caspase-9, and thereby can block the apoptotic processreside in cells as inactive proforms, and in most cases
at this point (Deveraux et al., 1998). It may also bind tocan be activated by proteolytic cleavage at two sites;
and inhibit caspase-3. Caspase binding and inhibition isone between the large and small subunits of what will be
mediated by its BIR domains (baculovirus IAP repeats),the mature enzyme and one that removes the prodomain
which are necessary and sufficient for IAP function. An-(reviewed in Wolf and Green, 1999). This occurs in two
other region, the RING domain, acts as a ubiquitin ligase,ways. The first is through the action of another protein-
promoting the degradation of XIAP (Yang et al., 2000)ase (usually a caspase) to mediate the cleavage. This
and possibly any caspase it is bound to. XIAP, andis the major way of activating executioner caspases.
probably other IAP molecules, put the brakes on the apo-The second is through the action of adaptor proteins
ptotic process by binding, inhibiting, and perhaps degrad-that bind protein interaction motifs in the prodomains
ing caspases. This effect is illustrated in Figure 1B.of ªinitiatorº caspases. This adaptor binding promotes
This inhibition has an interesting characteristic. Thethe activation of the initiator caspases, which can then
cleavage of caspase-3 by other proteinases occurs ingo on to cleave and activate the executioner caspases.
two steps, beginning with a cut between what will be theThese adaptor molecules link signaling events to cas-
large and small subunits. Following this cut, caspase-3pase activation, and define two basic pathways for apo-
then removes its own prodomain (Wolf and Green, 1999).ptosisÐthe mitochondrial pathway and the death recep-
If an IAP such as XIAP inhibits caspase-3, then the firsttor pathway.
cut can occur (e.g., by active caspase-8) but the second
will not, due to the block of caspase-3 activity (Deveraux* E-mail: dgreen5240@aol.com
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Figure 1. The Mitochondrial Pathway
Stress-induced signals are transduced to the mitochondria by the action of one or more members of the BH3-only subfamily of the proapoptotic
Bcl-2 proteins, acting on the Bax subfamily of proapoptotic Bcl-2 proteins. The mitochondria release cytochrome c and Smac/DIABLO. (A)
Cytochrome c induces the oligomerization of Apaf-1, which recruits and activates procaspase-9. The active caspase-9 recruits and activates
procaspase-3. The active caspase-3, and other executioner caspases, such as caspase-7, act on key substrates in the cell to orchestrate
apoptotic death. (B) IAPs (such as XIAP), can bind to activated caspase-9 and prevent its action on procaspase-3. The complex, perhaps, is
then ubiquitinated by the action of XIAP and degraded in the proteasome. (C) Smac/DIABLO binds XIAP, leaving caspase-9 free to recruit
and activate caspase-3, as in (A). Apoptosis therefore proceeds.
et al., 1998). The removal of the prodomain is not re- For example, microinjection of cytochrome c activates
caspases and induces apoptosis only in some cells (e.g.,quired for caspase-3 activity, but this partial cleavage
might serve as a ªfootprintº of IAP inhibition of caspase-3 Li et al., 1997) and Bcl-2 can interfere with apoptosis
induced by cytochrome c microinjection. Expression offunction. If XIAP also promotes ubiquitination and deg-
radation of the caspase, we may simply see loss of the IAPs and the control of Smac/DIABLO release may help
to explain these findings. Similarly, in neurons, the abilityproform without accumulation of the active subunits.
Derepressing Apoptosis by Blocking IAP Function: of injected cytochrome c to trigger apoptosis depends
on another signal, regulated by survival factors such asPaper Wraps Stone
Now, a new player has come into the picture. A protein NGF (Deshmukh and Johnson, 1998). This control of
ªcompetence to dieº may also involve the regulation ofwith the dual name of Smac/DIABLO (Du et al., 2000;
Verhagen et al., 2000; both in this issue of Cell) is re- IAPs and Smac/DIABLO.
Death Receptors and Bcl-2: Scissors Cut Paperleased from the mitochondria along with cytochrome c
during apoptosis, and this protein functions to promote Wrap Stone
The astute reader may have noticed that I have appar-caspase activation by associating with the Apaf-1 apo-
ptosome and inhibiting XIAP. Cytochrome c and Smac/ ently lost my metaphor: Paper (Smac/DIABLO) wraps
stone (IAPs) which blunts scissors (caspases), but doDIABLO are released coordinately, Apaf-1 is activated,
caspase-9 is inhibited, Smac/DIABLO relieves the inhibi- scissors cut paper?Ði.e., can caspase activation ever
promote the release of Smac/DIABLO to promote apo-tion, and apoptosis proceeds. But why build the system
this way with two levels of control? The key may be in ptosis? Here is where we have an opportunity to begin
to unify the apoptotic pathways.the way Smac/DIABLO is released. Unlike cytochrome
c, Smac/DIABLO is not present in S100 extracts; a small Death receptors, such as Fas/CD95 (as well as TNFR1,
DR3, and the TRAIL receptors) trigger caspase activa-amount of detergent must be added to the mitochondria
(Du et al., 2000). And yet, Smac/DIABLO is released tion through a different type of apoptosome, one that
is assembled and resides on the cytosolic region of theduring apoptosis. Therefore, perhaps, the control of
Smac/DIABLO release and that of cytochrome c (neither ligated death receptor itself (reviewed in Green, 1998).
Upon ligation of the receptor, adaptor proteins such asof which is fully understood) are different, and this may
introduce another level of regulation, ultimately de- FADD are recruited, and these in turn recruit procas-
pases (in particular caspases-8 and -10). By beingtermining whether a cell lives or dies.
The existence of a second mitochondrial participant in brought into proximity with one another, these procas-
pases cleave their nearest neighbors and active, maturethe apoptotic pathway could shed some light on earlier
observations that were otherwise difficult to explain. caspases form. The active caspases now efficiently
Minireview
3
Figure 2. Possible Control of Death Recep-
tor±Mediated Apoptosis by Bcl-2 in a ªType
IIº Cell
Ligation of the death receptor recruits adap-
tor molecules (such as FADD) and procas-
pases (such as procaspase-8 and -10) to the
receptor, where the caspases activate by
proximity. (A) The active initiator caspases
then act on procaspase-3, introducing a cut
between the small and large subunits. The
active caspase-3 is now bound and inhibited
by an IAP such as XIAP. (Although shown to
occur in vitro, this scenario in death receptor
signaling is currently speculative.) (B) The ac-
tive initiator caspases also cleave and acti-
vate Bid, which translocates to the mitochon-
dria and triggers Bax-subfamily proteins to
induce the release of Smac/DIABLO (as well
as cytochrome c, which in this speculative
scenario may be ancillary). Smac/DIABLO
binds to and neutralizes the IAP, allowing full
activation of the caspase-3 to occur (either
via caspase-8, or by cytochrome c±activated
caspase-9). Apoptosis proceeds. However, if
the cells express Bcl-2 (or Bcl-xL) then inhibi-
tion of the effect of Bid will prevent the release
of Smac/DIABLO, and apoptosis will be inhib-
ited. Although speculative, this scheme helps
to explain a number of reported phenomena
and makes a number of testable predictions.
cleave procaspase-3 (and other executioner caspases) does) by expression of XIAP. (b) Type II cells can be
converted to type I cells (i.e., the Bcl-2 inhibition canand apoptosis proceeds.
Clearly, this pathway does not require the involvement be bypassed) by expression of cytosolic Smac/DIABLO
(e.g., by removal of the mitochondrial localizing se-of mitochondria, and Bcl-2 should have no effect on
the process. In several cases, this is true. However, quence; Du et al., 2000). (c) In type II cells expressing
Bcl-2, activation of caspase-8 by death receptor ligationpersistent reports assert that Bcl-2 can inhibit death
receptor±triggered apoptosis, and this has led to the will induce the cleavage of caspase-3 between the large
and small subunits, but cleavage of the prodomain willcontroversial idea that there are two different cell types.
In ªtype Iº cells, death receptor signaling is not blocked not occur (see above). (d) In type II cells, death receptor
ligation will lead to ubiquitination and degradation ofby Bcl-2 and in ªtype IIº cells it is (Scaffidi et al., 1998).
The mechanisms linking death receptor signaling to a caspase-3 through the action of the XIAP ring finger.
There are, of course, other possibilities based on theBcl-2 inhibitable pathway came with the finding that
the BH3-only subfamily protein Bid is cleaved by active role of mitochondrial release of Smac/DIABLO, and its
regulation by Bcl-2.caspase-8, and the activated truncated Bid (tBid) targets
mitochondria to trigger Bax oligomerization and cyto- One or more of these predictions, if upheld, will help
to verify or refute the model in Figure 2. Further, thischrome c release (reviewed in Green, 1998).
But is cytochrome c the key player being released? model can easily be extended to other situations. For
example, in some cells, cytochrome c release appearsFigure 2 shows another possible scenario, in which the
activation of caspase-3 by caspase-8 is blocked by an to involve a ªfeed-forwardº pathway in which caspase-3
activation leads to Bid cleavage and more cytochromeIAP (such as XIAP), and therefore Smac/DIABLO is re-
quired to spring this IAP trap and release the active c release (Slee et al., 2000). It may well be that in some
circumstances amplified mitochondrial involvement viacaspase. In this scenario, Bid cleavage triggers the mito-
chondria to release Smac/DIABLO and this is blocked truncated Bid brings Smac/DIABLO into the process,
and this is needed to promote apoptosis.by Bcl-2 or Bcl-xL. Cytochrome c release is similarly
controlled but may not be relevant in this particular case. Bugs in the System?
So far, I have focused entirely on apoptotic pathwaysThis would explain the results of the experiment in which
Bcl-xL expression blocked Fas-mediated apoptosis and in the chordates, but although the process of apoptotic
cell death probably occurs in all other animal phyla, itcytochrome c release, but microinjection of cytochrome
c failed to bypass the effect to promote apoptosis (Li may not be the same. Comparisons could be informa-
tive. In Drosophila, apoptosis is initiated by expressionet al., 1997). If this model proposed here is correct,
then it was Smac/DIABLO, not cytochrome c, that was of Reaper and/or its genomic neighbors, Grim and Hid
(reviewed in White, 2000). For example, the recentlyneeded to bypass the Bcl-xL block in this system.
The model proposed in Figure 2 makes several predic- identified Drosophila p53 homolog induces Reaper ex-
pression. Reaper, Grim, and Hid then appear to havetions, and all are readily testable: (a) Type I cells, in
which Bcl-2 does not block death receptor±mediated two functions. One is to participate in an apoptotic path-
way that involves the Drosophila Apaf-1 homolog, Arkapoptosis, can be converted to type II cells (where it
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(White, 2000). Although this may involve mitochondria substitute for caspase-3, what substitutes for caspase-9?
(Drosophila Reaper induces cytochrome c release from Similarly, thymus cells lacking Apaf-1 can reportedly
mitochondria in vertebrate cell extracts), there is cur- undergo apoptosis in response to stress signals. Cellular
rently no compelling evidence implicating cytochrome stress can induce expression of ligands for death recep-
c in the activation of Ark and caspases in arthropods. tors or increase sensitivity for death receptor signaling,
The other major function of Reaper, Grim, and Hid lies but the importance of these pathways in mediating stress-
in the N termini of these proteins and involves a blockade induced apoptosis remains controversial. There may be
of IAP function and derepression of caspase activity yet another pathway, another route to caspase activation,
(e.g., Goyal et al., 2000). The parallels (analogy, not ho- to be uncovered and integrated into our models.
mology) with the function of Smac/DIABLO are obvi- So far, we have focused much of our attention on
ousÐboth probably involve the mitochondrial pathway XIAP, which is widely expressed in transformed cells
(although in different ways) and both block IAP function. but far from ubiquitous, especially in primary cells. Is
But these are not the same molecules (Smac/DIABLO there another player that might provide additional in-
is not a Reaper homolog) and therefore Smac/DIABLO sights for regulation of these apoptotic pathways? Per-
may be a relatively recent evolutionary invention. haps so. Smac/DIABLO binds several of the IAPs, in-
The nematode C. elegans presents another apoptotic cluding c-IAP1, c-IAP2, and survivin, although we do
pathway. CED-4, the Apaf-1 homolog (although lacking not know if it has any effects on their antiapoptotic
the WD repeat region), binds and activates the caspase
activities. These IAPs provide additional links between
CED-3 (Chen et al., 2000). CED-9, the Bcl-2 homolog,
cell cycle, death receptors, and the apoptotic pathways,sequesters CED-4 to the mitochondrial membrane and
and their regulation may be a key feature of the controlinhibits its access to CED-3. Apoptosis proceeds when
of cell death. The mitochondria (Smac/DIABLO release)a BH3-only protein, Egl-1, releases CED-4. Other than
and the nuclear-derived IAPs are engaged in a life-and-using mitochondria as a scaffold, there appears to be
death game of scissors/stone/paper that may be thelittle similarity between the C. elegans pathway and the
vestiges of a very old competition that has gone on forvertebrate pathways we've described. One easy ªoutº
hundreds of millions, or even billions of years.is to propose that it is simply different: CED-9 and Bcl-2
do not function in the same way. However, we are faced Selected Reading
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